http://archive.fast-edgar.com/20261013/AUZZB22CZW22SJZ2222L2ZZZAMMGZ6V8QK82
Filed on: October 13, 2026
http://archive.fast-edgar.com/20261013/AQ2W322CZ222E2Z222292M4W883HZE223282
Filed on: October 13, 2026
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
City Therapeutics, Inc.
(Exact name of registrant as specified in its charter)
Delaware 93-2762122 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) ... (continue reading...)
United States
Securities and Exchange Commission
Washington, D.C. 20549
SCHEDULE 14A
(Rule 14a-101)
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant ⌧
Filed by a Party other than the Registrant ◻
Check the appropriate box:
◻
Preliminary Proxy Statement
◻
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
◻
Definitive Proxy Statement
⌧
Definitive Additional Materials
◻
Soliciting... (continue reading...)
More SEC Filings
View Older Stories-
Form 144 ETSY INC Filed by: Silverman Josh
-
Form 144 BETA Technologies, Inc. Filed by: Clark Kyle
-
Form 4 WILLIS TOWERS WATSON For: Oct 09 Filed by: Pullum Anne
-
Form 144 AMKOR TECHNOLOGY, INC. Filed by: Faust Megan
-
Form N-8A Nuveen Enhanced Strategi
-
Form DEFA14A Senti Biosciences Holdin
-
Form 144 Everpure, Inc. Filed by: Singh Ajay
-
Form S-1 EuroSPAC Acquisition
-
Form 144 IDT CORP Filed by: SILBERMAN MITCH
-
Form 10-K OKMIN RESOURCES, INC. For: Jun 30
-
Form S-8 Alibaba Group Holding
-
Form 6-K DAQO NEW ENERGY CORP. For: Oct 13
-
Form DEF 14A Marathon Bancorp, Inc. For: Nov 17
-
Form 4 WILLIS TOWERS WATSON For: Oct 09 Filed by: Qureshi Imran Ahmed
-
Form SCHEDULE 13G ArriVent BioPharma, Inc. Filed by: Vivo Opportunity Fund Holdings, L.P.
-
Form 8-K Senti Biosciences Holdin For: Oct 08
-
Form 6-K Nano Labs Ltd For: Oct 13
-
Form 4 QumulusAI, Inc. For: Oct 09 Filed by: Bissell Robert Christopher
-
Form D/A Mojo Ventures Fund I,
-
Form SCHEDULE 13G Knight-Swift Transportat Filed by: PointState Capital LP
-
Form 8-K/A Tarsus Pharmaceuticals, For: Sep 04
-
Form 6-K TOWER SEMICONDUCTOR LTD For: Oct 13
-
Form PRE 14A JOHN HANCOCK VARIABLE For: Jan 05
-
Form 8-K NEPHROS INC For: Oct 13
-
Form 4 Credo Technology Group For: Oct 08 Filed by: Fleming Daniel W.
-
Form DEFA14A Strategy Inc
-
Form 10-K ESCALON MEDICAL CORP For: Jun 30
-
Form 6-K MATERIALISE NV For: Oct 13
-
Form 144 PINTEREST, INC. Filed by: Silbermann Benjamin
-
Form DEF 14A EGAIN Corp For: Dec 04
-
Form 4 CYTOKINETICS INC For: Oct 12 Filed by: Blum Robert I
-
Form 8-K Niki BioSolutions, Inc. For: Oct 13
-
Form FWP ROYAL BANK OF CANADA Filed by: ROYAL BANK OF CANADA
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 4 Strategy Inc For: Oct 08 Filed by: Patten Jarrod M
-
Form 8-A12B Iambic Therapeutics,
-
Form 424B2 HSBC USA INC /MD/
-
Form FWP BARCLAYS BANK PLC Filed by: BARCLAYS BANK PLC
-
Form 424B2 HSBC USA INC /MD/
-
Form 13F-HR 4WEALTH ADVISORS, INC. For: Sep 30
-
Form D Dvant Pharma, Inc.
-
Form D/A Blue Impact Fund II, LP
-
Form 424B2 WELLS FARGO & COMPANY/MN
-
Form 424B2 HSBC USA INC /MD/
-
Form 424B2 HSBC USA INC /MD/
-
Form 424B2 HSBC USA INC /MD/
-
Form 424B2 WELLS FARGO & COMPANY/MN
-
Form D Praxis Tech, Inc.
-
Form F-6 Gunnison Copper Corp./AD Filed by: BANK OF NEW YORK / ADR DIVISION
-
Form 8-K Destra Multi-Alternative For: Oct 13
